Global T-Cell Immunotherapy Market Research Report 2017


#931632

122pages

QYResearch

$ 2900

In Stock

Notes:
Production, means the output of T-Cell Immunotherapy
Revenue, means the sales value of T-Cell Immunotherapy

This report studies T-Cell Immunotherapy in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering
Adaptimmune
Altor Bioscience Corporation
Cellectis
Cell Therapy Catapult
Juno Therapeutics
Kite Pharma
Novartis
Takara Bio
Unum Therapeutics
Abingworth
ARCH Venture Partners
Acorn Campus Ventures
Adaptimmune
AFA F?rs?kring
AGF Private Equity
AgonOx
Agreen Biotech
Aju IB Investment
Alaska Permanent Fund
Alexandria Ventures
Allos Therapeutics
Amgen
Applied Immune Technologies
Aquilo Capital Management
Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of T-Cell Immunotherapy in these regions, from 2011 to 2021 (forecast), like
North America
Europe
China
Japan
Southeast Asia
India
Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into
CAR-T
TCR
TIL Therapies
Split by application, this report focuses on consumption, market share and growth rate of T-Cell Immunotherapy in each application, can be divided into
Hematological Malignancies
Solid Tumors
Others